Organoid Therapeutics, Inc. — Form D
Organoid Therapeutics, Inc. of IRWIN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-19. The offering totals $1.5M, of which $445K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-03-19
- Form: D
- Accession: 0001807052-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $445K
- Remaining: $1.1M
- Investors: 9
- Date of first sale: 2020-03-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-363242
Issuer
- Name: Organoid Therapeutics, Inc.
- CIK: 0001807052
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 10096 STELLA DE ORO DR., IRWIN, PA, 15642
- Phone: 724-961-6125
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Denver Faulk | Director | Irwin, PA |
| Ricardo Londono | Director | Irwin, PA |
| Denver Faulk | Executive Officer | Irwin, PA |
| Ricardo Londono | Executive Officer | Irwin, PA |
| David S Smith | Executive Officer | Raynham, MA |
More